Study of Orofacial Pain and PropRANOlol

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 20, 2015

Primary Completion Date

April 4, 2018

Study Completion Date

April 25, 2018

Conditions
Temporomandibular Disorders
Interventions
DRUG

Propranolol ER

Capsules given orally according to schedule at Visit 1, Visit 2, Visit 3, and Visit 4.

DRUG

Placebo

Gelatin capsules with a microcrystalline cellulose filler manufactured to mimic propranolol ER 60 mg capsules

Trial Locations (3)

14214

University at Buffalo School of Dental Medicine, Buffalo

27599

University of North Carolina at Chapel Hill School of Dentistry, Chapel Hill

32610-0404

University of Florida-Gainesville College of Dentistry, Gainesville

All Listed Sponsors
collaborator

University of Florida

OTHER

collaborator

Rho, Inc.

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

collaborator

State University of New York at Buffalo

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT02437383 - Study of Orofacial Pain and PropRANOlol | Biotech Hunter | Biotech Hunter